首页> International urology and nephrology> Ruling out clinically significant prostate cancer with negative multi-parametric MRI.

Ruling out clinically significant prostate cancer with negative multi-parametric MRI.

导出 OA

翻译打印收藏纠错

第一作者： Julie Y,An

第一单位： Center for Interventional Oncology, NIH Clinical Center, National Cancer Institute, National Institutes of Health, 10 Center Drive, Building 10, Bethesda, MD, 20814, USA. julieyajiean@gmail.com.

作者： Julie Y,An ^[1] ; Abhinav,Sidana ^[2] ; Sarah A,Holzman ^[3] ; Joseph A,Baiocco ^[4] ; Sherif,Mehralivand ^[5] ; Peter L,Choyke ^[5] ; Bradford J,Wood ^[6] ; Baris,Turkbey ^[5] ; Peter A,Pinto ^[4]

作者单位： Center for Interventional Oncology, NIH Clinical Center, National Cancer Institute, National Institutes of Health, 10 Center Drive, Building 10, Bethesda, MD, 20814, USA. julieyajiean@gmail.com. ^[1] Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.;Division of Urology, University of Cincinnati College of Medicine, Cincinnati, OH, USA. ^[2] Department of Urology, Georgetown University School of Medicine, Washington, DC, USA. ^[3] Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. ^[4] Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. ^[5] Center for Interventional Oncology, NIH Clinical Center, National Cancer Institute, National Institutes of Health, 10 Center Drive, Building 10, Bethesda, MD, 20814, USA. ^[6]

关键词 Active surveillance Biopsy Imaging Multi-parametric MRI Oncology PI-RADS v2 Prostate cancer